Probiyotiklerin Sınıflandırılması ve Antibiyotik İlişkili İshalin Önlenmesinde Probiyotiklerin Yeri
Özet
Referanslar
Zhang L, Zeng X, Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (>65 years): a systematic review and meta-analysis. BMC Geriatr. 2022 Jul 6;22(1):562. doi: 10.1186/s12877-022-03257-3.
Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793-801. doi: 10.1111/apt.13344.
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021 Aug 12;11(8):e043054. doi: 10.1136/bmjopen-2020-043054.
Czerucka D, Piche T, Rampal P. Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78. doi: 10.1111/j.1365-2036.2007.03442.x.
Alsammar H, Delneri D. An update on the diversity, ecology and biogeography of the Saccharomyces genus. FEMS Yeast Res. 2020 May 1;20(3):foaa013. doi: 10.1093/femsyr/foaa013.
Ono J, Greig D, Boynton PJ. Defining and Disrupting Species Boundaries in Saccharomyces. Annu Rev Microbiol. 2020 Sep 8; 74:477-495. doi: 10.1146/annurev-micro-021320-014036.
Pais P, Almeida V, Yılmaz M, Teixeira MC. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078.
McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202.
Marchesi JR. Adams DH. Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65:330–9.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144.
Zheng Yuejie,Wu Qingbin,Fang Feng, etc. Expert consensus on the diagnosis, treatment and prevention of antibiotic-associated diarrhea in children[J]. Chinese Journal of Practical Clinical Pediatrics, 2021, 36(6): 424-430. doi: 10.3760/cma.j.cn101070-20210201-00137.
Xu Yingchun,Zhang Man. Expert consensus on the diagnosis and treatment of Clostridium difficile infection in adults in China[J]. Medical Journal of Peking Union Medical College Hospital, 2017,8(2):131-138doi: 10.3969/j.issn.1674-9081.2017.03.011.
Referanslar
Zhang L, Zeng X, Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (>65 years): a systematic review and meta-analysis. BMC Geriatr. 2022 Jul 6;22(1):562. doi: 10.1186/s12877-022-03257-3.
Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793-801. doi: 10.1111/apt.13344.
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021 Aug 12;11(8):e043054. doi: 10.1136/bmjopen-2020-043054.
Czerucka D, Piche T, Rampal P. Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78. doi: 10.1111/j.1365-2036.2007.03442.x.
Alsammar H, Delneri D. An update on the diversity, ecology and biogeography of the Saccharomyces genus. FEMS Yeast Res. 2020 May 1;20(3):foaa013. doi: 10.1093/femsyr/foaa013.
Ono J, Greig D, Boynton PJ. Defining and Disrupting Species Boundaries in Saccharomyces. Annu Rev Microbiol. 2020 Sep 8; 74:477-495. doi: 10.1146/annurev-micro-021320-014036.
Pais P, Almeida V, Yılmaz M, Teixeira MC. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078.
McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202.
Marchesi JR. Adams DH. Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65:330–9.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144.
Zheng Yuejie,Wu Qingbin,Fang Feng, etc. Expert consensus on the diagnosis, treatment and prevention of antibiotic-associated diarrhea in children[J]. Chinese Journal of Practical Clinical Pediatrics, 2021, 36(6): 424-430. doi: 10.3760/cma.j.cn101070-20210201-00137.
Xu Yingchun,Zhang Man. Expert consensus on the diagnosis and treatment of Clostridium difficile infection in adults in China[J]. Medical Journal of Peking Union Medical College Hospital, 2017,8(2):131-138doi: 10.3969/j.issn.1674-9081.2017.03.011.
